Project Number 3P01AG017216-10S2 Agency/Funding Organization NIA Funding Year 2011 View Full Project Details for TAU AND NEURODEGENERATION II: A THERAPEUTIC TARGET Research Categorization Primary Disease / Condition Alzheimer's Disease Frontotemporal Dementia CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 2. Tau c. Tau-Mediated Pathogenesis (AD and ADRD) Researcher and Organization Principal Investigator DICKSON, DENNIS WILLIAM Principal Investigator First Name DENNIS Principal Investigator Last Name DICKSON Awardee Organization MAYO CLINIC JACKSONVILLE Awardee State Florida Contact PI Country United States Project Detail FY Overall Cost $100,000 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MILLER, MARILYN Related Resources Repository [NIAGADS] Progressive Supranuclear Palsy (PSP) GWAS [NIAGADS] Mayo GWAS [AlzPED] Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice. [AlzPED] Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice
